--2021/FY250.471M / 277.660M--
XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
Hangzhou Gaoxin Materials Technology
300478
Beijing Philisense Technology
300287
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Read more